Oxford BioDynamics (OXBOF) AI Stock Analysis

Oxford BioDynamics

(Other OTC:OXBOF)

Rating:―N/A

Action:N/A

Date:―

No summary available

Positive Factors

Revenue GrowthRevenue growth of 22.21% indicates that Oxford BioDynamics is expanding commercial activity despite current losses. Continued top-line progress can support greater test adoption, partner engagement, and operating leverage if growth eventually outpaces the company’s cost base.

Negative Factors

Persistent LossesPersistent negative net, gross, and EBIT margins show that revenue growth has not yet translated into a profitable operating model. Until pricing, volume, or cost efficiency improves, ongoing losses may constrain reinvestment and weaken the company’s ability to fund expansion internally.

Oxford BioDynamics (OXBOF) vs. SPDR S&P 500 ETF (SPY)

Not enough price history over this period.

Market Cap: $2.29M
Dividend Yield: ―
Average Volume (3M): ―
Price to Earnings (P/E): -0.3
Beta (1Y): 1.18
Revenue Growth: 40.26%
EPS Growth: 85.56%
Country: US
Employees: 37
Sector: Healthcare
Sector Strength: 51
Industry: Biotechnology

Oxford BioDynamics Business Overview & Revenue Model

Company Description

Oxford BioDynamics Plc operates as a biotechnology firm that specializes in identifying and advancing biomarkers, primarily for the pharmaceutical and biotechnology sectors across global markets, including the United States. Its flagship offering is...

Oxford BioDynamics Peers Comparison

Overall Rating

UnderperformOutperform

Sector (51)

Financial Indicators

OXBOF against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
GB:IXI	64Neutral	GBP 25.73M	-5.99	-16.18%	―	13.04%	15.88%
GB:SBTX	59Neutral	GBP 13.61M	-29.17	-5.25%	―	95.16%	85.60%
Sector *	51Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
GB:FAB	49Neutral	GBP 7.51M	-6.06	-97.87%	―	7.38%	44.13%
GB:APTA	43Neutral	GBP 10.23M	-9.83	-46.61%	―	28.35%	57.14%
GB:GENF	42Neutral	GBP 10.85M	-8.29	609.63%	―	―	56.00%

* Healthcare Sector Average

Performance Comparison

OXBOF and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
OXBOF	Oxford BioDynamics	―	―	―
GB:IXI	IXICO plc	11.75	0.25	2.17%
GB:SBTX	SkinBioTherapeutics plc	5.25	-10.88	-67.44%
GB:FAB	Fusion Antibodies Plc	6.00	-7.50	-55.56%
GB:GENF	Genflow Biosciences Plc	1.82	-0.25	-12.05%
GB:APTA	Aptamer Group Plc	0.29	-0.51	-63.13%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Oxford BioDynamics AI Stock Analysis